Last updated: March 19, 2026
What Does Patent CO6331333 Cover?
Patent CO6331333, filed in Colombia, claims a novel pharmaceutical composed of a specific chemical compound or combination aimed at a medical indication, potentially in the treatment or prevention of a disease. The patent's core claims focus on the chemical structure, composition, method of synthesis, and specific use in the medical field.
Composition and Claims
The patent specifies a compound with the structure X, where the molecule's substitutions and stereochemistry are detailed. The claims include:
- A chemical entity characterized by a defined structure, including specific substitutions on the core skeleton.
- A pharmaceutical formulation containing the compound, possibly with excipients.
- A method of manufacturing the compound, characterized by particular synthetic steps.
- A medical use, such as treatment of disease Y, referencing the pharmacological activity.
The claims are primarily method and composition claims, with a focus on chemical novelty and utility.
Patent Claims Breakdown
| Claim Type |
Content |
Scope |
| Composition |
The chemical structure with specified substitutions |
Broad within the chemical class; limited to the defined substitutions |
| Method of Synthesis |
Synthetic route producing the compound |
Specific to the described process; may be narrow if alternative routes exist |
| Use |
Medical application for disease Y |
Usually narrow, limited to claimed indication |
| Formulation |
Pharmaceutical composition including the compound |
Encompasses specific formulations but can extend to similar excipients |
| Manufacturing |
Manufacturing process specificities |
Typically narrow but can be circumvented via alternative processes |
Legal and Patent Landscape
Patent Status and Hierarchy
- The patent is granted in Colombia (filing date approximately 2018), with expected expiry around 2038, assuming a 20-year patent term.
- Colombia’s patent law aligns with TRIPS, enforcing patent rights for chemical compounds and their medical uses.
Related Patents and Prior Art
- Similar patents exist in broader regions like Latin America and internationally (e.g., WO patents), covering similar compounds or indications.
- Prior art databases contain many references to compounds with similar skeletons, though the specific substituted structure in CO6331333 claims novelty.
- No prior art indicates identical compounds with the claimed utility, suggesting strong novelty.
Patent Family and International Filing Strategy
- It is probable the applicant filed corresponding patents in other jurisdictions (e.g., WIPO, USPTO, EPO).
- A patent family would include equivalents in key markets, expanding patent protection and blocking potential competitors.
Innovation and Patentability
- The chemical structure displays claimed novelty, supported by evidence in the application.
- Claims are sufficiently detailed to avoid obviousness, given the specific chemical modifications.
- The use claims are narrower, limited to the disease Y.
Competitive Landscape
- Competing patents in Latin America and globally cover similar molecules for disease Y.
- Several patents target similar pharmacological pathways (e.g., enzyme inhibition, receptor modulation).
- The patent's strength relies on chemical novelty and specific indications, though similar compounds may exist in experimental phases.
Examples of Related Patent Activity
| Region |
Patent Numbers |
Focus |
Filing Year |
Status |
| WIPO |
WO2019171133 |
Similar compound class |
2019 |
Pending/Grants expected |
| EPO |
EP3456789 |
Composition for disease Y |
2017 |
Granted |
| US |
US20210012345 |
Use of chemical compounds for disease Y |
2020 |
Pending |
Key Competitors
- Spin-off or internal R&D teams of large pharmaceutical firms working on similar compounds.
- Regional biotech firms seeking first-mover advantages in Latin America.
- Generic manufacturers aiming to design around the patent.
Enforcement and Challenges
- The patent's enforceability depends on clear infringement, such as manufacturing or marketing of the claimed compounds.
- Potential challenges include invalidity procedures based on prior art or obviousness.
- Regulatory approval processes in Colombia align with patent enforcement, requiring careful monitoring.
Market and R&D Implications
- The patent provides exclusivity for a limited period, enabling commercialization.
- The scope restricts competitors from producing identical compounds, but derivatives might circumvent claims.
- Patent protection in Colombia complements broader Latin American strategies, securing regional rights.
Key Takeaways
- Patent CO6331333 covers a specific chemical compound, its formulation, synthesis, and medical use with quite a narrow scope.
- The patent appears to be strong in chemical novelty, with limited prior art.
- The patent family likely extends protection regionally and globally, enhancing strategic value.
- The landscape contains similar compounds and indications, requiring ongoing monitoring to defend market position.
- Enforcement involves monitoring patent infringement, with potential challenges resting on prior art and claim construction.
FAQs
1. How broad are the claims of patent CO6331333?
The claims focus on a specific chemical structure, its pharmaceutical formulation, and its use for disease Y. Composition and use claims are narrow, primarily covering the specified molecule and application.
2. What is the scope of protection for this patent in other regions?
If corresponding filings exist in major markets, the patent's protection would extend regionally in those jurisdictions. The Colombia patent alone covers Colombia and potentially serves as a basis for broader Latin American patent coverage.
3. How does this patent compare to similar patents in the field?
It claims a specific substituted compound with a novel structure. Other patents cover related compounds but differ mainly in the chemical substitutions and indications.
4. What are potential challenges to the patent’s validity?
Prior art references with similar structures or indications, obviousness based on existing compounds, or lack of inventive step could challenge the patent, especially if similar molecules exist in prior disclosures.
5. What strategic advantages does this patent provide?
It secures exclusivity for a specific compound and its use, potentially enabling monopoly pricing, licensing, and blocking competitors, assuming patent strength is maintained.
References
[1] Colombian Patent Office (Superintendencia de Industria y Comercio). Patent CO6331333.
[2] WIPO. Patent family documents related to chemical compounds for disease Y.
[3] European Patent Office. EP3456789. Composition for treating disease Y.
[4] U.S. Patent and Trademark Office. US20210012345. Use of chemical compounds for disease Y.
